Skip to main content
ACADEMIC TECHNOLOGIES at:
INSTITUTE of CARDIOVASCULAR MEDICINE

Spezielle Literatur Combyn™ ECG

  • Skrabal F, Weber T, Skrabal K, Windhaber J, Ehsas H, Stockinger N, Boyer J. Measurement of aortofemoral volume wave velocity during the routine 12-channel ECG: relation to age, physiological hemoglobin A 1C, triglycerides and SBP in healthy individuals. J Hypertens. 2020 Oct;38(10):1989-1999. Article
  • Skrabal F, Pichler GP, Gratze G, Holler A. Adding „hemodynamic and fluid leads“ to the ECG. Part I: the electrical estimation of BNP, chronic heart failure (CHF) and extracellular fluid (ECF) accumulation. Med Eng Phys 2014 Jul;36(7):896-904. Article
  • Skrabal F, Pichler GP, Penatzer M, Steinbichl J, Hanserl AK, Leis A, Loibner A. The Combyn TM ECG: Adding haemodynamic and fluid leads for the ECG. Part II: Prediction of total body water (TBW), extracellular fluid (ECF), ECF overload, fat mass (FM) and “dry”appendicular muscle mass (AppMM). Med Eng Phys 2017 Jun;44:44-52. Article
  • Skrabal F. Das Combyn™-ECG „Made in Austria“: neues 12-Kanal-Routine-EKG eröffnet umfangreiche Diagnosemöglichkeiten. Jatros Kardiologie & Gefäßmedizin 1/2017. Article
  • Skrabal F & Skrabal K. Sarkopenische Adipositas und das metabolische Syndrom: Risikoerfassung während des Routine-12-Kanal-EKG mit Hilfe des CombynTM ECG. Universum Innere Medizin 06/18;58-60. Article

 

 

Allgemeine Literatur

  • 1 Entsprechend den gesetzlichen EU Richtlinien sind nicht etablierte Messparameter, für die es keine sicheren Standards gibt, als „for research purposes only“ ausgewiesen.
  • 2 Skrabal F, Pichler GP, Gratze G, Holler A. Adding „hemodynamic and fluid leads“ to the ECG. Part I: the electrical estimation of BNP, chronic heart failure (CHF) and extracellular fluid (ECF) accumulation. Med Eng Phys 2014 Jul;36(7):896-904. Article
  • 3 Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: A review of bioimpedance spectroscopy (BIS) and impedance analysis (BIA) methods. Med Eng Phys. 2008 Dec;30(10):1257-69. Pubmed
  • 4 Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, Boutouyrie P, Cameron J, Chen CH, Cruickshank JK, Hwang SJ, Lakatta EG, Laurent S, Maldonado J, Mitchell GF, Najjar SS, Newman AB, Ohishi M, Pannier B, Pereira T, Vasan RS, Shokawa T, Sutton-Tyrell K, Verbeke F, Wang KL, Webb DJ, Willum Hansen T, Zoungas S, McEniery CM, Cockcroft JR, Wilkinson IB. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014 Feb 25;63(7):636-46. Article
  • 5 Mattace-Raso F, Hofman A, Verwoert GC, Wittemana JC, Wilkinson I, Cockcroft J, McEniery C, Yasmin, Laurent S, Boutouyrie P, Bozec E, Hansen TW, Torp-Pedersen C, Ibsen H, Jeppesen J, Vermeersch SJ, Rietzschel E, De Buyzere M, Gillebert TC, Van Bortel L, Segers P, Vlachopoulos C, Aznaouridis C, Stefanadis C, Benetos A, Labat C, Lacolley P, Stehouwer C, Nijpels G, Dekker JM, Stehouwer C, Ferreira I, Twisk JW, Czernichow S, Galan P, Hercberg S, Pannier B, Guérin A, London G, Cruickshank JK, Anderson SG, Paini A, Agabiti Rosei E, Muiesan ML, Salvetti M, Filipovsky J, Seidlerova J, Dolejsova M. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010 Oct;31(19):2338-50. Article.
  • 6 Rose BD. Edematous states.In: Clinical physiology of acid–base and electrolyte disorders. 5th ed. New York: McGraw-Hill; 2001. p.478–523. Link
  • 7 von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):261-3. Article
  • 8 Habedank D, Meyer FJ, Hetzer R, Anker SD, Ewert R. Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure. J Cachexia Sarcopenia Muscle. 2013 Dec;4(4):277-85. Article
  • 9 Haigh K, Bingley J, Golledge J, Walker PJ. Peripheral arterial disease - screening in general practice. Aust Fam Physician. 2013 Jun;42(6):391-5. Article
  • 10 Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ; Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. German Epidemiological Trial on Ankle Brachial Index Study Group. Circulation. 2009 Nov 24;120(21):2053-61. Article
  • 11 Skrabal F, Pichler GP, Penatzer M, Steinbichl J, Hanserl AK, Leis A, Loibner A. The Combyn TM ECG: Adding haemodynamic and fluid leads for the ECG. Part II: Prediction of total body water (TBW), extracellular fluid (ECF), ECF overload, fat mass (FM) and “dry”appendicular muscle mass (AppMM). Med Eng Phys 2017 Jun;44:44-52. Article
  • 12 Skrabal F. Das Combyn™-ECG „Made in Austria“: neues 12-Kanal-Routine-EKG eröffnet umfangreiche Diagnosemöglichkeiten. Jatros Kardiologie & Gefäßmedizin 1/2017. Article
  • 13 Skrabal F. and Skrabal K. Sarkopenische Adipositas und das metabolische Syndrom: Risikoerfassung während des Routine-12-Kanal-EKG mit Hilfe des CombynTM ECG. Universum Innere Medizin 06/18;58-60. Article

 

 Die Literatur wird laufend aktualisiert.

Impressum © Falko Skrabal Institut f. Herzkreislauf- und Stoffwechselmedizin GmbH, Dept. Academic Technologies
Mariatrosterstraße 67 | A-8043 Graz | T +43 316 67 67 67 | office@ac-tc.at